RxDoctor Payments Data

Lisa Radice

Nurse Practitioner · Fort Collins, CONPI 1982757845

Payments from drug & device makers

$966in general payments, 2019–2025

Across 12 payments — averaging $80.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$194
  • Johnson & Johnson$181
  • Intuitive Surgical$127
  • Stemline Therapeutics Inc.$127
  • AstraZeneca$125
  • Daiichi Sankyo Inc.$93
  • plus $119 from 3 others

What the payments were for

  • Food & beverage$966100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$966 in reported general payments places this provider in the 80th percentile of 1,384 nurse practitioner providers in Colorado.

See all nurse practitioner providers in Colorado

Medicare billing

Part B allowed, 2024
$44,311
Medicare patients
236
Services billed
497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AlunbrigBrigatinib12$241,091
VenclextaVenetoclax12$162,841
Abiraterone Acetate21$63,727
XareltoRivaroxaban17$21,546
EliquisApixaban16$17,775
Potassium Chloride53$1,083
Dexamethasone67$656
Ondansetron Hcl24$535
Acyclovir37$500
Gabapentin31$498
Ondansetron OdtOndansetron16$418
Levothyroxine Sodium46$406
Hydroxyurea32$380
Oxycodone Hcl18$356
Prednisone75$330

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$181$21,54617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,384 nurse practitioner providers in Colorado.

Other nurse practitioner in Fort Collins

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →